Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

angiotensin/obesity

リンクがクリップボードに保存されます
ページ 1 から 133 結果

Obesity Surgery During 2020 Italian Pandemic

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Background Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) . The disease was first identified in December 2019 in Wuhan, the capital of China's Hubei province, and has since spread globally, resulting in the ongoing

Investigation of Safety and Efficacy of CARDIO Softgels in Former Smokers and Asthma Patients With COVID-19 Infection

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
SARS-CoV-2, a plus-sense single-stranded RNA virus, is the etiologic agent of COVID-19. After an incubation period, which typically lasts for 5-6 days, COVID-19 patients present with a mild illness that lasts for a few days. Common symptoms are reminiscent of the flu, and include fever, dry cough

Determining the Reproductive Health of Men Post-COVID-19 Infection

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Male infertility results from impaired sperm function, and account for half of all infertility. Fertility services have been reported to cost £325M annually in the UK(4) (REF). Testosterone deficiency is one of the most common hormonal problems affecting men, leading to osteoporosis, type 2

Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
An association between the presence of previous cardiovascular disease and adverse prognosis has been demonstrated in patients with COVID-19 (coronavirus disease-19), presenting increases of up to 5-10 times in mortality. As an initial process, the SARS-CoV-2 virus, anchored in the transmembrane

COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX)

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
COVID-19 is pandemic and, though it primarily affects the lungs, there is evidence of cardiovascular system involvement. Mechanistically, SARS-CoV-2, following proteolytic cleavage of its S protein by a serine protease, binds to the transmembrane angiotensin-converting enzyme 2 (ACE2) —a homologue

Relation Between Plasma Apelin Level and Diabetic Nephropathy in Type 2 Diabetes Patients.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Introduction Type 2 Diabetes Mellitus is a metabolic syndrome associated with hyperglycemia due to defect in secretion or action of insulin or both. Long term hyperglycemia leads to complications of microvasculature involving the eyes, kidneys and nerves. Diabetic nephropathy (DN) is the commonest

Leptin Infusion and Endothelial Vasomotor Response

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Introduction High BMI and particularly fat mass index are associated with increased risk of coronary artery disease and other cardiovascular conditions, but the underlying mechanisms are not well understood. Endothelial dysfunction precedes atherosclerosis and represents an important link between

Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Background COVID-19 has shown a lower case-fatality rate compared to other major viral outbreaks in contemporary history, including severe acute respiratory syndrome (SARS) of 2002-2003. However, the relative susceptibility to symptomatic infection and the case fatality risk increase substantially

Liver Injury in Patients With COVID-19

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Scenario Multicenter study of patients hospitalized with SARS-CoV-2 in different institutions in Latin America and directed by the Coronavirus and Liver interest group of the Latin American Association for the Study of the Liver (ALEH), coordinated by Dr. Marcelo Silva. This project has been

SGLT2 Inhibitors in Glomerular Hyperfiltration

登録ユーザーのみが記事を翻訳できます
ログインサインアップ

CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
CandeSpartan Study Candesartan Spanish Response-prediction and Tolerability study Observational study on response predictors and tolerability of Candesartan in usual clinical practice INTRODUCTION: Migraine is a neurological disease with a prevalence of 14% of the population 1, 2. It is the second

Evaluation of Intestinal Microbiota Manipulation to Treat Resistant Hypertension

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
The gastrointestinal tract begins its colonization shortly after the birth. During the first two years of life, microbiota is unstable and less diverse than in adulthood, when its complexity and diversity are modified. There are more than 100 trillion microorganisms hosted in the gut, mostly as

Renohemodynamic Effects of Combined empagliflOzin and LosARtan

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Diabetic kidney disease (DKD), characterized by reduced whole-kidney glomerular filtration rate (GFR) and/or urinary protein leakage, is a feared complication of type 2 diabetes (T2DM). With severe consequences such as endstage kidney disease (ESKD) and renal death, and strongly linked to

Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fraction

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Heart failure with preserved ejection fraction (HFpEF) is increasing in incidence and accounts for one third to one half of all heart failure admissions worldwide. It portrays a significant burden in terms of prevalence, morbidity and mortality. It is a complex clinical syndrome characterized by

Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
According to European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) Guidelines for the management of arterial hypertension 2018 in case of previous combination at full dose does not allow to achieve the target Blood Pressure (BP), that therapy might be switch to
Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge